Phase I Study of Feasibility of Single Session Spine Stereotactic Radiosurgery (SSRS) in the Primary Management in Patients With Inoperable, Previously Unirradiated Metastatic Epidural Spinal Cord Compression (MESCC)

Metastatic Epidural Spinal Cord Compression Clinical Trial

Official title: Phase I Study of Feasibility of Single Session Spine Stereotactic Radiosurgery (SSRS) in the Primary Management in Patients With Inoperable, Previously Unirradiated Metastatic Epidural Spinal Cord Compression (MESCC)

Status Active, not recruiting

Clinical Trial Summary

The goal of this clinical study is to learn the feasibility of using a single session of radiation, known as spine stereotactic radiosurgery (SSRS), to treat metastatic epidural spinal cord compression.

Clinical Trial Description

Spinal cord compression is often treated with surgery followed by radiation in small doses everyday for a number of days. When a patient cannot or will not have surgery, radiation is given daily. With increased accuracy and precision, higher doses of radiation can be given in a single session. Giving a higher dose in a single session may increase the chance that the tumor will stop growing into the spinal canal and will prevent spinal cord injury. This study will also help to identify the tolerance of the spinal cord to radiation in a single session. Spine Stereotactic Radiosurgery: You will lie in the mold that was made for you for 45-120 minutes while you receive your radiation treatment. Follow-up Visits: You will have follow-up visits at Months 3 (+/-2 weeks ), 6 (+/-4 weeks), 9 (+/-4 weeks), 12 (+/-8 weeks), 18 (+/-8 weeks), and 24 (+/-8 weeks) and then every 6 months after that. At each follow-up visit: - Your medical history will be recorded, including any use of steroids. - You will have a neurological exam. - You will complete the 3 questionnaires about health, symptoms you may be having, and about pain. - You will have an MRI of the spine (except for Month 1). If you are unable to return for follow-up clinic visits, you will be called and asked about your medical history, and you will complete the 3 questionnaires about your health, symptoms you may be having, and about pain. This call should take about 20 minutes. Length of Study: Your treatment will last 1 day. You will continue having follow-up visits or phone calls for as long as possible. This is an investigational study. SSRS is FDA approved. The use of SSRS to treat metastatic epidural spinal cord compression is investigational. Up to 36 patients will take part in this study. All will be enrolled at M. D. Anderson. ;

Related Conditions & MeSH terms

• Metastatic Epidural Spinal Cord Compression
• Spinal Cord Compression

• NCT number: NCT01254903
• Study type: Interventional
• Source: M.D. Anderson Cancer Center
• Status: Active, not recruiting
• Phase: Phase 1
• Start date: December 3, 2010
• Completion date: April 1, 2025